Press Release: Nordic-MUbio announces the acquisition of An Der Grub Bio Research GmbH
11 December 2013
Susteren, The Netherlands / Vienna, Austria – December 2013 – Nordic-MUbio, a leading manufacturer of immunological reagents is pleased to announce its acquisition of all assets of An Der Grub Bio Research GmbH (ADG). ADG is the manufacturer of FIX & PERM® – a best in class product used in the $3.1bn Flow Cytometry market (BCC Research Report, October 2013) for the fixation and permeabilization of single‐cell suspensions.
The acquisition of ADG further expands the Nordic-MUbio product catalogue after the acquisition of MUbio by Nordic Immunological Labs in February 2013 and consolidates Nordic-MUbio’s position as one of the key upcoming companies in the research reagent market. Nordic-MUbio is a primary manufacturer of antibodies suitable for research in the fields of Cell Biology, Immunology and Flow Cytometry and is renowned for antibodies exhibiting a high level of multi-species reactivity.
“We are looking forward to adding the ADG product range into the Nordic-MUbio portfolio” said Ronald Rutten, CEO of Nordic-MUbio. “ADG’s products are of very high quality and their growth potential is exceptional. All assets have been transferred to the Nordic-MUbio offices in Susteren, The Netherlands and Monika Schermann (Marketing and Sales Manager, ADG) will be supporting our production and technical departments for the next three months to get things up and running.
ADG’s best-selling product is FIX & PERM® which is used extensively in Flow Cytometry and allows cells to be identified in flow cytometry by their light scatter properties and surface maker expression, while simultaneously being analysed for intracellular antigens. FIX & PERM® and ADG’s other products are already available for sale through Nordic-MUbio and we will be selling them through our distributors and partners located around the world.
“We are happy to have found a party where our products will be brought to a higher platform and our successful brand FIX&PERM® will be marketed worldwide so even more researchers and laboratories will be able to use it” said Brigitte Knapp, retiring CEO of ADG.
Nordic-MUbio was created in February 2013 by the acquisition of MUBio BV by Nordic Immunological Laboratories. Nordic-MUbio’s headquarters is based in Susteren, The Netherlands and all products are manufactured according to strict ISO 9001 quality guidelines.
Nordic-MUbio is a primary manufacturer of high quality antibody reagents for use in research & development and, after the integration of ADG production and QC, the IVD market.
Ronald Rutten, DVM MBA
Chief Executive Office